After trying different methods, why do many people have difficulty quitting smoking? That’s a question Rachel Tyndale, Ph.D., is asking as part of her research into smoking cessation therapy. As senior scientist and head of the Pharmacogenetics Lab in the Campbell Family Mental Health Research Institute at University of Toronto, Dr. Tyndale is using molecular genetics, pharmacokinetics and pharmacogenomics to better understand differences in medication toxicity and response. Her team is exploring how a person’s genes impact addiction and drug response to develop better, individualized therapies for people who want to quit smoking.
As a plenary speaker at this year’s Individualizing Medicine Conference, Dr. Tyndale will share her research in her presentation Pharmacogenomic Optimization of Smoking Cessation. Mayo Clinic Center for Individualized Medicine will host the conference on Oct. 9-10, in Rochester, Minnesota.
This year’s conference also features many other opportunities to learn about pharmacogenomics, an area of precision medicine that has made great strides in individualizing patient care for many conditions. Here are highlights from this year’s program:
Pharmacogenomics: Practical Approach for the Healthcare Team
This preconference course, held Oct. 7-8, will be taught by Mayo Clinic experts, including Richard Weinshiilboum, M.D., Eric Matey, Pharm.D., R.Ph., and Wayne Nicholson, M.D., Pharm. D., who are leaders in bringing pharmacogenomics into clinical practice. Participants will learn:
Pharmacogenomics: From Sequencing to the Clinic
Moderated by Liewei Wang, M.D., Ph.D., this conference session will feature:
The topics to be discussed include:
Pharmacogenomics CME courses for clinicians and pharmacists:
Register for the 2017 Individualizing Medicine Conference
Hear the experts listed above and many others discuss the latest research in precision medicine and how it can be applied to improve diagnosis and treatment for many conditions at Individualizing Medicine 2017: Advancing Care Through Genomics.
Mayo Clinic Center for Individualized Medicine, is hosting the sixth annual genomics conference, October 9–10, in Rochester, Minnesota.
Mayo Clinic Center for Individualized Medicine is hosting the conference with support from the Jackson Family Foundation.
Tags: #CIMCon17, #DNA analysis, #Dr. J. Steven Leeder, #Dr. Rachel Tyndale, #drug-gene reactions, #Individualizing Medicine 2017, #preemptive pharmacogenomics, #smoking cessation, center for individualized medicine, DNA Sequencing, Dr. Eric Matey, Dr. Liewei Wang, Dr. Richard Weinshilboum, Dr. Stephen Scherer, Dr. Suzette Bielinski, Dr. Wayne Nicholson, Genetic Testing, mayo clinic, medical research, personalized medicine, pharmacogenomics, Precision Medicine